Lixin Wang
- Molecular Biology
- Oncology top 10%
- Immunology top 10%
- Cancer Research top 10%
- Genetics
- Co-authors
- Didier MerlinShanthi V. SitaramanAndrew T. GewirtzBaljit WaliaKevin A. JanesJoan S. BruggeJohn P. EvansJesse Roman
- Topics
- Peptidase Inhibition and Analysis (5 papers)Inflammatory Biomarkers in Disease Prognosis (3 papers)Cancer Cells and Metastasis (2 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lixin Wang
31 papers receiving 997 citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 431
- Oncology 286
- Immunology 219
- Cancer Research 194
- Genetics 164
Countries citing papers authored by Lixin Wang
This map shows the geographic impact of Lixin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin Wang more than expected).
Fields of papers citing papers by Lixin Wang
This network shows the impact of papers produced by Lixin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin Wang. The network helps show where Lixin Wang may publish in the future.
Co-authorship network of co-authors of Lixin Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Lixin Wang. A scholar is included among the top collaborators of Lixin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixin Wang. Lixin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 6 | |
| 8 | 7 | |
| 9 | 9 | |
| 10 | 25 | |
| 11 | 93 | |
| 12 | 3 | |
| 13 | 27 | |
| 14 | 33 | |
| 15 | 38 | |
| 16 | 20 | |
| 17 | 62 | |
| 18 | 231 | |
| 19 | 193 | |
| 20 | 8 |
About Lixin Wang
Lixin Wang is a scholar working on Oncology, Immunology and Allergy and Internal Medicine, having authored 35 papers that have together received 1.0k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (194 citations), Oncology (286 citations) and Immunology (219 citations). Lixin Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Didier Merlin, Shanthi V. Sitaraman, Andrew T. Gewirtz, Baljit Walia, Kevin A. Janes, Joan S. Brugge, John P. Evans, Jesse Roman, Vasantha L. Kolachala and Pallavi Garg. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.